Clinical Trial Update: Phase II Trial of Vandetanib in Children and Adults With Wild-Type Gastrointestinal Stromal Tumors [Phase 2]

View source ↗

Summary

Phase II trial of vandetanib in children and adults with wild-type gastrointestinal stromal tumors (GIST) completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Stromal Tumor

Drugs mentioned

• Vandetanib (vandetanib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: GIST | Phase 2 | Status: COMPLETED | Results posted: 2019-07-23